Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Viremia D014766 4 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Burns, Inhalation D002059 4 associated lipids
Shock, Traumatic D012774 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Liver Failure D017093 5 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Zang BX et al. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor]. 2004 Zhongguo Zhong Yao Za Zhi pmid:15506296
Bankers-Fulbright JL et al. Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils. 2004 J. Cell. Sci. pmid:15507482
Hertelendy F and Zakár T Prostaglandins and the myometrium and cervix. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:14683694
Diez-Fraile A et al. Effect of proinflammatory mediators and glucocorticoids on L-selectin expression in peripheral blood neutrophils from dairy cows in various stages of lactation. 2004 Am. J. Vet. Res. pmid:15524330
Mangan NE et al. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. 2004 J. Immunol. pmid:15528374
Jung TT et al. Effect of inhibitors of leukotriene and/or platelet activating factor on killed H. influenzae induced experimental otitis media with effusion. 2004 Int. J. Pediatr. Otorhinolaryngol. pmid:14687688
Barbanoj MJ et al. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. 2004 Neuropsychobiology pmid:15539863
Fujii S et al. Chromogenic assay for the activity of sphingomyelinase from Bacillus cereus and its application to the enzymatic hydrolysis of lysophospholipids. 2004 Biol. Pharm. Bull. pmid:15516713
Hla T Prostaglandins & other lipid mediators: a new phase, a new team. 2004 Prostaglandins Other Lipid Mediat. pmid:15165026
Ruan Z et al. Effects of platelet-activating factor and thromboxane A2 on isolated perfused guinea pig liver. 2004 Prostaglandins Other Lipid Mediat. pmid:15165033
Nomikos TN et al. Application of a TCA-precipitation method for the determination of 1-alkyl-sn-glycero-3-phosphate: Acetyl-CoA acetyltransferase in human renal tissue. 2004 Prostaglandins Other Lipid Mediat. pmid:15165037
Kato M et al. Dual signaling and effector pathways mediate human eosinophil activation by platelet-activating factor. 2004 Int. Arch. Allergy Immunol. pmid:15166482
Besana A et al. Activation of protein kinase C epsilon inhibits the two-pore domain K+ channel, TASK-1, inducing repolarization abnormalities in cardiac ventricular myocytes. 2004 J. Biol. Chem. pmid:15184378
Michail S and Abernathy F A new model for studying eosinophil migration across cultured intestinal epithelial monolayers. 2004 J. Pediatr. Gastroenterol. Nutr. pmid:15187782
Wang Y et al. Opposing effect of angiopoietin-1 on VEGF-mediated disruption of endothelial cell-cell interactions requires activation of PKC beta. 2004 J. Cell. Physiol. pmid:14584044
Takeda K [Role of increase in permeability and circulatory failure in the development of organ dysfunction in severe acute pancreatitis]. 2004 Nippon Rinsho pmid:15552880
Takase K et al. [New aspects of pharmaco-therapy for acute pancreatitis]. 2004 Nippon Rinsho pmid:15552891
Rothhut B Benveniste's reputation was not written in water. 2004 Nature pmid:15565124
Serradji N et al. Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity. 2004 J. Med. Chem. pmid:15566310
Zhu L et al. Internalization of caveolin-1 scaffolding domain facilitated by Antennapedia homeodomain attenuates PAF-induced increase in microvessel permeability. 2004 Am. J. Physiol. Heart Circ. Physiol. pmid:12946927
Roudebush WE et al. Platelet-activating factor significantly enhances intrauterine insemination pregnancy rates in non-male factor infertility. 2004 Fertil. Steril. pmid:15236989
Alloatti G et al. Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease. 2004 Biochem. Soc. Trans. pmid:15046613
Shio MT et al. PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells. 2004 Exp. Cell Res. pmid:15242784
Naoki K et al. PAF responsiveness in Japanese subjects with plasma PAF acetylhydrolase deficiency. 2004 Biochem. Biophys. Res. Commun. pmid:15047169
Al-Darmaki S et al. Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response. 2004 Clin. Diagn. Lab. Immunol. pmid:15242947
Sugatani J et al. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation. 2004 Int. Arch. Allergy Immunol. pmid:15051936
Tsironis LD et al. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase. 2004 Cardiovasc. Res. pmid:15194469
Aguiari G et al. Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells. 2004 FASEB J. pmid:15001556
Ma YQ et al. P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. 2004 Blood pmid:15217824
Du YM et al. Effects of platelet activating factor on action potentials and potassium channels in guinea-pig ventricular myocytes. 2004 Sheng Li Xue Bao pmid:15224138
Geromin D et al. Glycoprotein 170 induces platelet-activating factor receptor membrane expression and confers tumor cell hypersensitivity to NK-dependent cell lysis. 2004 J. Immunol. pmid:15004162
McDonagh PF et al. Chronic expression of platelet adhesion proteins is associated with severe ischemic heart disease in type 2 diabetic patients: Chronic platelet activation in diabetic heart patients. 2003 Sep-Oct J. Diabetes Complicat. pmid:12954156
Kerek M et al. Effects of recombinant platelet activating factor acetylhydrolase in obstructive jaundice. 2003 Jul-Aug Hepatogastroenterology pmid:12845989
Baltás E et al. Platelet-activating factor antagonist WEB 2086 inhibits ultraviolet-B radiation-induced dermatitis in the human skin. 2003 Jul-Aug Skin Pharmacol. Appl. Skin Physiol. pmid:12784066
Hsueh W et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. 2003 Jan-Feb Pediatr. Dev. Pathol. pmid:12424605
Diez-Fraile A et al. Analysis of selective mobilization of L-selectin and Mac-1 reservoirs in bovine neutrophils and eosinophils. 2003 Jan-Feb Vet. Res. pmid:12588684
Tellis C et al. Localization of an alkyl-acetyl-glycerol-CDP-choline: cholinephosphotransferase activity in submitochondrial fractions of Tetrahymena pyriformis. 2003 Eur. J. Cell Biol. pmid:14703014
Stafforini DM et al. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. 2003 Crit Rev Clin Lab Sci pmid:14708958
Narahara H et al. Platelet-activating factor inhibits the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages. 2003 J. Clin. Endocrinol. Metab. pmid:14671207
Gálvez J et al. The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production. 2003 Inflamm. Bowel Dis. pmid:14671485
Ishizuka S et al. Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. 2003 J. Infect. Dis. pmid:14673774
Koyama N Platelet activating factor in surfactant-TA is inhibited by coexisting inhibitors. 2003 Lung pmid:14692561
Zhu X et al. Structural determinants of blockade of eosinophil activation, adhesion and secretion by synthetic analogs of phomactin. 2003 Life Sci. pmid:14519449
Møller CH and Steinbrüchel DA Platelet function after coronary artery bypass grafting: is there a procoagulant activity after off-pump compared with on-pump surgery? 2003 Scand. Cardiovasc. J. pmid:12881156
Guarino MP et al. PAF-like lipids- and PAF-induced gallbladder muscle contraction is mediated by different pathways in guinea pigs. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12936911
Curry FE et al. Thrombin increases permeability only in venules exposed to inflammatory conditions. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12893636
Mayer K et al. Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. 2003 Intensive Care Med pmid:12897994
Shen Z et al. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions. 2003 Planta Med. pmid:12898414
de Assis EF et al. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes. 2003 J. Immunol. pmid:12902515
Hu H et al. Glycoprotein IIb/IIIa inhibition attenuates platelet-activating factor-induced platelet activation by reducing protein kinase C activity. 2003 J. Thromb. Haemost. pmid:12911597
Kalia N and Bardhan KD Of blood and guts: association between Helicobacter pylori and the gastric microcirculation. 2003 J. Gastroenterol. Hepatol. pmid:12911655
Tokuoka SM et al. Involvement of platelet-activating factor and LIS1 in neuronal migration. 2003 Eur. J. Neurosci. pmid:12911752
Lupia E et al. Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions. 2003 Int. J. Mol. Med. pmid:12883648
Handa RK et al. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo. 2003 Kidney Blood Press. Res. pmid:12886044
Taggart DP et al. Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonist. 2003 Heart pmid:12860868
Brandt EB et al. Mast cells are required for experimental oral allergen-induced diarrhea. 2003 J. Clin. Invest. pmid:14660743
Rhee CK Candidate's thesis: Platelet-activating factor-induced hearing loss: mediated by nitric oxide? 2003 Laryngoscope pmid:14660903
Diaper CM et al. A total synthesis of (+/-)-phomactin A. 2003 Org. Biomol. Chem. pmid:14664384
Beck-Speier I et al. Sulfur-related air pollutants induce the generation of platelet-activating factor, 5-lipoxygenase- and cyclooxygenase-products in canine alveolar macrophages via activation of phospholipases A2. 2003 Prostaglandins Other Lipid Mediat. pmid:14518563
Antonopoulou S et al. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients. 2003 Mediators Inflamm. pmid:14514473
Gödecke A PAF, PIP(3) and NO: emerging role in reperfusion injury. 2003 Cardiovasc. Res. pmid:14613846
Alloatti G et al. Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. 2003 Cardiovasc. Res. pmid:14613853
Akisu M et al. Supplementation with Saccharomyces boulardii ameliorates hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. 2003 Eur J Pediatr Surg pmid:14618522
Toledo AA et al. Fertilization potential of human sperm is correlated with endogenous platelet-activating factor content. 2003 J. Assist. Reprod. Genet. pmid:12812462
Souza DG et al. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. 2003 Br. J. Pharmacol. pmid:12812996
Brown RA et al. Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro. 2003 Br. J. Pharmacol. pmid:12813008
Abu-Zidan FM Comment on "Low-dose ethanol alters the cardiovascular, metabolic, and respiratory compensation for severe blood loss". 2003 J Trauma pmid:12813357
Toledo DP et al. Microvascular reactivity in experimental diabetes: responses of male and female rats. 2003 Inflamm. Res. pmid:12813623
Tonks AJ et al. Regulation of platelet-activating factor synthesis in human monocytes by dipalmitoyl phosphatidylcholine. 2003 J. Leukoc. Biol. pmid:12832447
Choi IW et al. Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction. 2003 J. Exp. Med. pmid:12835479
Proudfoot JM et al. Angiotensin II type 1 receptor antagonists inhibit basal as well as low-density lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1. 2003 J. Pharmacol. Exp. Ther. pmid:12626661
Fang HY et al. Cyclooxygenase-2 in human non-small cell lung cancer. 2003 Eur J Surg Oncol pmid:12633561
Witko-Sarsat V et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. 2003 Kidney Int. pmid:12787398
Slomiany BL and Slomiany A Platelet-activating factor modulates gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. 2003 Biochem. Biophys. Res. Commun. pmid:12788098
Schuster DP et al. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial. 2003 Crit. Care Med. pmid:12794395
Rabinovici R Platelet activating factor inhibition in sepsis: the end? 2003 Crit. Care Med. pmid:12794432
Li XG and Luo HM [Progress in studies of chemical constituents and pharmacological activities of Kadsura]. 2003 Zhongguo Zhong Yao Za Zhi pmid:15617488
Wierzbicki T et al. IL-4 primes human endothelial cells for secondary responses to histamine. 2003 J. Leukoc. Biol. pmid:12949246
Khanna A et al. Beneficial effects of intraluminal nitroglycerin in intestinal ischemia-reperfusion injury in rats. 2003 J. Surg. Res. pmid:13678693
Bazan NG Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. 2003 J. Lipid Res. pmid:13130128
Chatterjee SS et al. Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators. 2003 Pharmacopsychiatry pmid:13130392
Mahgoub AA Thymoquinone protects against experimental colitis in rats. 2003 Toxicol. Lett. pmid:12749817
Mariano F et al. Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production. 2003 Shock pmid:12688545
Thaete LG et al. Infusion of exogenous platelet-activating factor produces intrauterine growth restriction in the rat. 2003 J. Soc. Gynecol. Investig. pmid:12699876
Simon HU et al. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome. 2003 Eur. J. Immunol. pmid:12672048
Teather LA and Wurtman RJ Cyclooxygenase-2 mediates platelet-activating factor-induced prostaglandin E2 release from rat primary astrocytes. 2003 Neurosci. Lett. pmid:12672535
Kordan W et al. Functions of platelet activating factor (PAF) in mammalian reproductive processes: a review. 2003 Pol J Vet Sci pmid:12675470
Loucks EB et al. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart. 2003 Can J Cardiol pmid:12677282
Ginesta MM et al. Modulation of the pathology of late xenograft rejection by PAF-antagonist UR-12670 in the hamster-to-rat liver xenotransplant model. 2003 APMIS pmid:12752216
Ueda Y et al. Effects on blood pressure decrease in response to PAF of Impatiens textori MIQ. 2003 Biol. Pharm. Bull. pmid:14519965
Akisu M et al. The role of dietary supplementation with L-glutamine in inflammatory mediator release and intestinal injury in hypoxia/reoxygenation-induced experimental necrotizing enterocolitis. 2003 Ann. Nutr. Metab. pmid:14520021
Frostegård J et al. Antibodies against platelet-activating factor and platelet-activating factor-like lipids are raised in women with primary recurrent abortion. 2003 Am. J. Obstet. Gynecol. pmid:14520236
Ahlemeyer B and Krieglstein J Neuroprotective effects of Ginkgo biloba extract. 2003 Cell. Mol. Life Sci. pmid:14523543
Biancone L et al. Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth. 2003 Clin. Cancer Res. pmid:14519648
Gabbianelli R et al. A new method to evaluate spontaneous platelet aggregation in type 2 diabetes by Cellfacts. 2003 Clin. Chim. Acta pmid:12589971
D'Andrea G et al. Platelet aggregation profiles in cluster headache. 2003 Headache pmid:12603647
Gruska S et al. Sodium/lithium countertransport and intracellular calcium concentration in patients with essential hypertension and coronary heart disease. 2003 Clin. Sci. pmid:12605593
Lu DP et al. Ligand-activated signal transduction in the 2-cell embryo. 2003 Biol. Reprod. pmid:12606379
Hu G et al. Neutrophils pretreated with volatile anesthetics lose ability to cause cardiac dysfunction. 2003 Anesthesiology pmid:12606916
Corl CM et al. Oxidant stress enhances Lyso-PAF-AcT activity by modifying phospholipase D and phosphatidic acid in aortic endothelial cells. 2003 Biochem. Biophys. Res. Commun. pmid:12615078